ALVO - Alvotech


8.06
-0.260   -3.226%

Share volume: 210,875
Last Updated: 04-08-2025
Pharmaceutical Products/Biological Products, Except Diagnostic Substances: -0.07%

PREVIOUS CLOSE
CHG
CHG%

$8.32
-0.26
-0.03%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Fundamental analysis
0%
Profitability 0%
Dept financing 0%
Liquidity 0%
Performance 0%
Performance
5 Days
-5.18%
1 Month
-24.67%
3 Months
-40.38%
6 Months
-37.90%
1 Year
-32.44%
2 Year
-39.26%
Key data
Stock price
$8.06
P/E Ratio 
0.00
DAY RANGE
$8.04 - $8.89
EPS 
N/A
52 WEEK RANGE
$7.77 - $14.76
52 WEEK CHANGE
-$32.15
MARKET CAP 
2.854 B
YIELD 
N/A
SHARES OUTSTANDING 
301.482 M
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
05-20-2025
BETA 
0.54
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
$184,110
AVERAGE 30 VOLUME 
$136,221
Company detail
CEO: Mark L. PhD
Region: US
Website: alvotech.com
Employees: 4
IPO year: 2022
Issue type: Common Stock
Market: XNAS
Industry: Pharmaceutical Products/Biological Products, Except Diagnostic Substances
Sector: Manufacturing

N/A

Recent news
loading